Skip to main content

US Patent

 

Clinical courses

  • Kylin Therapeutics' pRNAi technology gets US patent

    Kylin Therapeutics, Inc, a leading RNAi company, announced that they have received patent from the US Patent and Trademark Office (US PTO).

Subscribe to US Patent